Our Products

We are leaders in the market for providing best range of Imbruvica Capsule, Ibrance Palbociclib Capsule and Desoxyn 5 Mg Tablets

Ibrance Palbociclib Capsule

₹ 73,200 / Bottle Get Latest Price

Min. Order (MOQ) 2 Bottle(s)

Palbociclib(codenamed PD-0332991, trade name Ibrance) is a drug for the treatment ofER-positive and HER2-negative breast cancer developed by Pfizer. It is a selective inhibitor of the cyclin-dependent kinases CDK4 and CDK6.

BRANCE is for postmenopausal women with ER+/HER2- metastatic breast cancer who have not received prior hormone therapy for their metastatic disease.

View Complete Details

Ask Latest Price & Details

Imbruvica Capsule

₹ 6.41 Lakh / Pack Get Latest Price

Min. Order (MOQ) 1 Pack(s)

Type of drug: Kinase inhibitor

Indication(s): Adults with mantle cell lymphoma who have received at least one prior therapy; chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL); CLL/SLL with 17p deletion; Waldenstrms macroglobulinemia; Marginal zone lymphoma who require systemic therapy and have received at least one prior anti-CD20-based therapy; Chronic graft-versus-host disease after failure of one or more lines of systemic therapy

View Complete Details

Ask Latest Price & Details